German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.
from Reuters: Science News https://ift.tt/2yWAFym
//
Tuesday, 23 October 2018
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment